Skip to main content

Helus Pharma Inc.

HELP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001833141

In the last 90 days, Helus Pharma Inc. insiders filed 8 open-market purchases and 0 sales; 99 institutions reported holding it in 13F filings for Q2 2026, worth $197.6M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Helus Pharma Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
8 filings
4 insiders, $8.42M in total
Open-market sells
0 filings
Insiders trading
4
Net value
+$8.42M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Helus Pharma Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Helus Pharma Inc.
NameTitleLast reported holdingLast filingFilings, past year
So Eric H. L.Director4,713,014Oct 1, 20264
Cavers GregChief Financial Officer3,000IndirectOct 1, 20261
Glavine PaulChief Growth Officer4,750,191Oct 1, 20265
Halstead MichaelChief Executive Officer168,568Sep 21, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 1, 2026 (view filing)8:13 PM ETSep 292 daysCavers GregChief Financial OfficerPPurchase+3.00K$12.91+$38.7KNew position3.00K after
Sep 21, 2026 (view filing)5:07 PM ETSep 21Same dayHalstead MichaelChief Executive OfficerPPurchase+100.0K$13.47+$1.35M+145.8%168.6K after
Sep 11, 2026 (view filing)9:04 AM ETSep 83 daysLateGlavine PaulChief Growth OfficerPPurchase+100.0K$12.47+$1.25M+2.4%4.27M afterDuplicate filing
Sep 11, 2026 (view filing)9:03 AM ETSep 83 daysLateGlavine PaulChief Growth OfficerPPurchase+100.0K$12.47+$1.25M+2.4%4.27M after
Sep 11, 2026 (view filing)9:01 AM ETSep 83 daysLateSo Eric H. L.Executive ChairPPurchase+100.0K$12.39+$1.24M+2.3%4.47M after
Sep 10, 2026 (view filing)6:21 AM ETSep 46 daysLateSo Eric H. L.Executive ChairPPurchase+100.0K$12.09+$1.21M+2.3%4.37M after
Sep 10, 2026 (view filing)6:19 AM ETSep 37 daysLateGlavine PaulChief Growth OfficerPPurchase+100.0K$11.78+$1.18M+2.5%4.17M after
Sep 9, 2026 (view filing)5:47 PM ETSep 18 daysLateSo Eric H. L.Executive ChairPPurchase+95.0K$11.81+$1.12M+2.3%4.27M after
Sep 9, 2026 (view filing)11:03 AM ETAug 319 daysLateGlavine PaulChief Growth OfficerPPurchase+90.0K$11.59+$1.04M+2.3%4.07M after